BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 71 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $363,738 | -7.6% | 284,170 | +0.4% | 0.00% | – |
| Q1 2023 | $393,488 | +6.9% | 283,085 | +0.0% | 0.00% | – |
| Q4 2022 | $367,936 | +1944.1% | 283,028 | +2230.4% | 0.00% | – |
| Q3 2022 | $18,000 | -73.9% | 12,145 | -64.0% | 0.00% | – |
| Q2 2022 | $69,000 | -45.2% | 33,761 | -27.0% | 0.00% | – |
| Q1 2022 | $126,000 | -94.6% | 46,275 | -90.4% | 0.00% | – |
| Q4 2021 | $2,351,000 | -58.0% | 479,907 | +8.4% | 0.00% | -100.0% |
| Q3 2021 | $5,601,000 | -18.0% | 442,766 | +0.2% | 0.00% | -50.0% |
| Q2 2021 | $6,829,000 | -9.2% | 441,728 | +93.3% | 0.00% | 0.0% |
| Q1 2021 | $7,519,000 | – | 228,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 415,039 | $431,641 | 1.06% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1,213,630 | 0.98% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1,967,126 | 0.78% |
| TANG CAPITAL MANAGEMENT LLC | 3,557,040 | $3,699,322 | 0.52% |
| Vivo Capital, LLC | 3,871,291 | $4,026,143 | 0.44% |
| Samsara BioCapital, LLC | 1,049,153 | $1,091,119 | 0.33% |
| Acuitas Investments, LLC | 460,379 | $478,794 | 0.28% |
| Newtyn Management, LLC | 1,020,000 | $1,060,800 | 0.26% |
| Sofinnova Investments, Inc. | 2,754,437 | $2,864,614 | 0.18% |
| Privium Fund Management (UK) Ltd | 116,516 | $121,177 | 0.10% |